author-photo

Nina Kimmeskamp-Kirschbaum

Bayer HealthCare Pharmaceuticals

11

Papers

634

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Pharmacokinetics, safety and tolerability of the novel, selective mineralocorticoid receptor antagonist finerenone – results from first-in-man and relative bioavailability studies

2016 Fundamental & Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (30)
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone (BAY 94–8862) in Individuals With Renal Impairment

2016 Clinical pharmacology in drug development
Show All
- Source
- Cite
- Save
Citations (25)
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease

2016 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (164)
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease: Rationale and design of ARTS-HF

2015 European Journal of Heart Failure
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial

2015 JAMA
Show All
- Source
- Cite
- Save
Citations (317)
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.

2015 European Journal of Heart Failure
Show All
- Source
- Cite
- Save
Citations (64)
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF)

2015 European Journal of Heart Failure
Show All
- Source
- Cite
- Save
Citations (1)
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.

2014 American Journal of Nephrology
Show All
- Source
- Cite
- Save
Citations (29)
Position Statement from ADA/AACE/EASD/TES in Response to a Recently Published Letter to the Editor in The Lancet and an Editorial Addressing the Israeli-Palestinian Fighting in Gaza

2014 American Journal of Nephrology
Show All
- Source
- Cite
- Save
Citations (1)
Contents Vol. 40, 2014

2014 American Journal of Nephrology
Show All
- Source
- Cite
- Save
Citations (0)